ARQT ARCUTIS BIOTHERAPEUTICS INC
2026Q1 · CUSIP 03969K108 · Sector: Healthcare & Biotech
Danger · Dual-confirm: breadth + price
Holders
265
Δ holders QoQ
-14
Breadth percentile
Top 89%
Whale holders
143
Δ whales
-3
Inst. holding value
$3.1B
New positions
41
Closed positions
55
Price momentum (1Q)
-24.7%
Put / Call
4/4
Breadth history (34 quarters)
Past Lit Events & Aftermath 6 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q4 | Top 12% | -24.7% | — |
| 2025Q1 | Top 6% | +7.7% | +78.8% |
| 2024Q2 | Top 15% | +17.0% | +53.0% |
| 2024Q1 | Top 8% | -6.0% | +0.7% |
| 2022Q3 | Top 4% | -11.8% | -50.8% |
| 2022Q1 | Top 13% | +28.6% | -0.5% |
Options Sentiment
Put holders
4
QoQ: -1
Call holders
4
QoQ: -1
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-0.02
EPS YoY
—
Revenue (TTM)
$0.4B
Revenue YoY
+95.3%
Net margin
-0.6%
ROE
-1.3%
Debt ratio
58.8%
FCF (TTM)
$27M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.